Cytokine‐stimulated astrocytes damage human neurons via a nitric oxide mechanism

Astrocytes have been reported to play a neuropathogenic role within the brain, although little is known about the mechanism underlying astrocyte‐mediated neuronal injury. We investigated the hypothesis that cytokine‐stimulated astrocytes adversely affect neuronal cell survival via generation of the free radical nitric oxide (NO). Primary human astrocytes produced substantial amounts of NO in response to interleukin (IL)‐1α or IL‐1β, which was blocked by the NO synthase inhibitor NG‐monomethyl‐L‐arginine (NMMA). IL‐1β‐induced NO production was markedly potentiated by interferon (IFN)‐γ. IL‐1 receptor agonist protein (IRAP) totally blocked NO generation by cytokine‐stimulated astrocytes. Using reverse transcription‐polymerase chain reaction and sequencing analyses of the astrocyte NO synthase gene, we found a single band encoding for a 615 bp product that was identical to the corresponding sequence reported for human hepatocytes. Treatment of human fetal brain cell cultures with IL‐1β plus IFN‐γ resulted in marked neuronal loss, as assessed by microscopic analysis and measurement of lactate dehydrogenase release. This cytokine‐induced neuronal damage was blocked by simultaneous treatment of the brain cell cultures with NMMA or IRAP, suggesting a critical role of IL‐1. These findings indicate that cytokine‐stimulated astrocytes are neurotoxic via a NO‐mediated mechanism and point to potential new therapies for neurodegenerative disorders that involve cytokines and reactive astrocytes. © 1996 Wiley‐Liss, Inc.

[1]  N. Schofield.  Rational Choice and Political Economy , 2017, The Rational Choice Controversy.

[2]  Shuxian Hu,et al.  Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. , 1995, The Journal of infectious diseases.

[3]  S. Lipton,et al.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV- associated neurological disease , 1995, The Journal of experimental medicine.

[4]  P. Peterson,et al.  Glia, cytokines, and neurotoxicity. , 1995, Critical reviews in neurobiology.

[5]  M. Tsang,et al.  Transforming growth factor- protects human neurons against -amyloid-induced injury , 1994 .

[6]  M. Shin,et al.  Tyrosine kinase activation by Newcastle disease virus is required for TNF-alpha gene induction in astrocytes. , 1994, Journal of immunology.

[7]  H. Esumi,et al.  Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172. , 1994, Journal of biochemistry.

[8]  Shuxian Hu,et al.  Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. , 1994, The Journal of infectious diseases.

[9]  N. Reiner,et al.  Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. , 1994, Immunology today.

[10]  A. Casadevall,et al.  Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism , 1994, The Journal of experimental medicine.

[11]  Fang Liu,et al.  Glutamate-mediated astrocyte–neuron signalling , 1994, Nature.

[12]  M. Nedergaard,et al.  Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. , 1994, Science.

[13]  E. Benveniste,et al.  Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. , 1994, Journal of immunology.

[14]  A. Casadevall,et al.  Reactive nitrogen intermediates in human neuropathology: an overview. , 1994, Developmental neuroscience.

[15]  D. Dickson,et al.  Macrophages and microglia in HIV-related CNS neuropathology. , 1994, Research publications - Association for Research in Nervous and Mental Disease.

[16]  Z. Fu,et al.  Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase , 1993, Journal of virology.

[17]  D. Reis,et al.  Synthesis of nitric oxide in CNS glial cells , 1993, Trends in Neurosciences.

[18]  D. Dickson,et al.  Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. , 1993, Journal of neuroimmunology.

[19]  E. El-Fakahany,et al.  beta-Amyloid 25-35 activates nitric oxide synthase in a neuronal clone. , 1993, Neuroreport.

[20]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[21]  S H Snyder,et al.  Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D W Dickson,et al.  Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. , 1993, Journal of immunology.

[23]  D Emilie,et al.  In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. , 1993, Journal of immunology.

[24]  M. Tsang,et al.  Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. , 1992, The Journal of clinical investigation.

[25]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[26]  S H Snyder,et al.  A novel neuronal messenger molecule in brain: The free radical, nitric oxide , 1992, Annals of neurology.

[27]  K. Boje,et al.  Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death , 1992, Brain Research.

[28]  J. Relton,et al.  Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat , 1992, Brain Research Bulletin.

[29]  C. Cotman,et al.  β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease , 1992, Brain Research.

[30]  R. Price,et al.  Human immunodeficiency virus and the central nervous system. , 1992, Annual review of microbiology.

[31]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today (Amsterdam. Regular ed.).

[32]  J. Merrill,et al.  HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  D. Dickson,et al.  Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[34]  C. Nathan,et al.  Role of nitric oxide synthesis in macrophage antimicrobial activity. , 1991, Current opinion in immunology.

[35]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor , 1990, Nature.

[36]  S. Styren,et al.  Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.

[37]  L. Lachman,et al.  Interleukin-1 stimulation of astroglial proliferation after brain injury. , 1985, Science.